Name | Number of supported studies | Average coverage | |
---|---|---|---|
erythroblast | 5 studies | 32% ± 11% | |
epithelial cell | 3 studies | 30% ± 5% | |
astrocyte | 3 studies | 19% ± 3% | |
erythrocyte | 3 studies | 32% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 726.43 | 180 / 180 | 100% | 3.56 | 430 / 430 |
prostate | 100% | 513.04 | 245 / 245 | 100% | 3.77 | 502 / 502 |
stomach | 100% | 395.16 | 359 / 359 | 100% | 4.02 | 286 / 286 |
intestine | 100% | 428.87 | 965 / 966 | 100% | 4.05 | 525 / 527 |
breast | 100% | 452.44 | 459 / 459 | 99% | 3.18 | 1112 / 1118 |
brain | 100% | 343.33 | 2631 / 2642 | 100% | 4.22 | 704 / 705 |
esophagus | 100% | 427.81 | 1445 / 1445 | 99% | 3.52 | 181 / 183 |
adrenal gland | 100% | 918.05 | 258 / 258 | 99% | 3.94 | 227 / 230 |
liver | 100% | 885.76 | 226 / 226 | 98% | 3.30 | 398 / 406 |
thymus | 100% | 452.07 | 653 / 653 | 98% | 2.85 | 593 / 605 |
uterus | 100% | 568.65 | 170 / 170 | 98% | 3.20 | 449 / 459 |
skin | 99% | 398.65 | 1794 / 1809 | 99% | 2.81 | 465 / 472 |
pancreas | 100% | 427.16 | 328 / 328 | 97% | 2.17 | 173 / 178 |
lung | 99% | 358.56 | 574 / 578 | 98% | 2.67 | 1128 / 1155 |
bladder | 100% | 626.00 | 21 / 21 | 95% | 2.86 | 481 / 504 |
kidney | 100% | 457.13 | 89 / 89 | 95% | 2.20 | 855 / 901 |
adipose | 100% | 445.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 3.78 | 29 / 29 |
muscle | 100% | 681.45 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 571.27 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.70 | 1 / 1 |
blood vessel | 100% | 312.66 | 1329 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 3.92 | 79 / 80 |
heart | 99% | 721.92 | 849 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 2.92 | 44 / 45 |
peripheral blood | 94% | 375.87 | 870 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035265 | Biological process | organ growth |
GO_0007628 | Biological process | adult walking behavior |
GO_0010039 | Biological process | response to iron ion |
GO_0006119 | Biological process | oxidative phosphorylation |
GO_0046716 | Biological process | muscle cell cellular homeostasis |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0018283 | Biological process | iron incorporation into metallo-sulfur cluster |
GO_0090201 | Biological process | negative regulation of release of cytochrome c from mitochondria |
GO_0016540 | Biological process | protein autoprocessing |
GO_0046621 | Biological process | negative regulation of organ growth |
GO_0009792 | Biological process | embryo development ending in birth or egg hatching |
GO_0006783 | Biological process | heme biosynthetic process |
GO_0006826 | Biological process | iron ion transport |
GO_0044572 | Biological process | [4Fe-4S] cluster assembly |
GO_0040015 | Biological process | negative regulation of multicellular organism growth |
GO_0043085 | Biological process | positive regulation of catalytic activity |
GO_0051349 | Biological process | positive regulation of lyase activity |
GO_0016226 | Biological process | iron-sulfur cluster assembly |
GO_0007005 | Biological process | mitochondrion organization |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_1904231 | Biological process | positive regulation of succinate dehydrogenase activity |
GO_0044571 | Biological process | [2Fe-2S] cluster assembly |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0019230 | Biological process | proprioception |
GO_0010722 | Biological process | regulation of ferrochelatase activity |
GO_1904234 | Biological process | positive regulation of aconitate hydratase activity |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_0099128 | Cellular component | mitochondrial [2Fe-2S] assembly complex |
GO_0005739 | Cellular component | mitochondrion |
GO_1990229 | Cellular component | iron-sulfur cluster assembly complex |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_1990221 | Cellular component | L-cysteine desulfurase complex |
GO_0004322 | Molecular function | ferroxidase activity |
GO_0034986 | Molecular function | iron chaperone activity |
GO_0008198 | Molecular function | ferrous iron binding |
GO_0008199 | Molecular function | ferric iron binding |
GO_0051537 | Molecular function | 2 iron, 2 sulfur cluster binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FXN |
Protein name | Frataxin Frataxin, mitochondrial (EC 1.16.3.1) Frataxin, mitochondrial (EC 1.16.3.1) (Friedreich ataxia protein) (Fxn) [Cleaved into: Frataxin intermediate form (i-FXN); Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN); Extramitochondrial frataxin] |
Synonyms | FRDA X25 hCG_2042989 |
Description | FUNCTION: [Frataxin mature form]: Functions as an activator of persulfide transfer to the scaffoding protein ISCU as component of the core iron-sulfur cluster (ISC) assembly complex and participates to the [2Fe-2S] cluster assembly . Accelerates sulfur transfer from NFS1 persulfide intermediate to ISCU and to small thiols such as L-cysteine and glutathione leading to persulfuration of these thiols and ultimately sulfide release . Binds ferrous ion and is released from FXN upon the addition of both L-cysteine and reduced FDX2 during [2Fe-2S] cluster assembly . The core iron-sulfur cluster (ISC) assembly complex is involved in the de novo synthesis of a [2Fe-2S] cluster, the first step of the mitochondrial iron-sulfur protein biogenesis. This process is initiated by the cysteine desulfurase complex (NFS1:LYRM4:NDUFAB1) that produces persulfide which is delivered on the scaffold protein ISCU in a FXN-dependent manner. Then this complex is stabilized by FDX2 which provides reducing equivalents to accomplish the [2Fe-2S] cluster assembly. Finally, the [2Fe-2S] cluster is transferred from ISCU to chaperone proteins, including HSCB, HSPA9 and GLRX5 (By similarity). May play a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe(2+) to Fe(3+); the oligomeric form but not the monomeric form has in vitro ferroxidase activity . May be able to store large amounts of iron in the form of a ferrihydrite mineral by oligomerization; however, the physiological relevance is unsure as reports are conflicting and the function has only been shown using heterologous overexpression systems . May function as an iron chaperone protein that protects the aconitase [4Fe-4S]2+ cluster from disassembly and promotes enzyme reactivation . May play a role as a high affinity iron binding partner for FECH that is capable of both delivering iron to ferrochelatase and mediating the terminal step in mitochondrial heme biosynthesis . .; FUNCTION: [Extramitochondrial frataxin]: Modulates the RNA-binding activity of ACO1 . May be involved in the cytoplasmic iron-sulfur protein biogenesis . May contribute to oxidative stress resistance and overall cell survival . . |
Accessions | ENST00000644653.1 ENST00000396366.6 [Q16595-3] A0A0S2Z3Q8 Q16595 A0A0S2Z3G4 ENST00000377270.8 ENST00000484259.3 [Q16595-1] ENST00000498653.5 ENST00000645088.1 C9JAX1 |